2024澳科资料1688-资料免费精选
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.12.31
关于公司使用自有资金购买低风险理财产品的进展公告
2016.12.31
关于签订《募集资金三方监管协议》的公告
2016.12.27
关于公司使用自有资金购买低风险理财产品的进展公告
2016.12.22
关于对外投资的完成公告
2016.12.22
关于开展交叉货币掉期业务的可行性分析报告
2016.12.22
关于公司拟与汇丰银行进行交叉货币掉期交易的公告
2016.12.22
第三届董事会第三十一次会议决议公告
2016.12.14
关于公司拟与平安银行进行交叉货币掉期交易的公告
2016.12.14
关于对控股子公司进行投资的公告
2016.12.14
关于向银行申请授信的公告
第一页
上一页
78
79
80
81
82
下一页
最后一页
